Skip to content

Temporomandibular Joint in Patients With Rheumatoid Arthritis

Temporomandibular Joint in Patients With Rheumatoid Arthritis

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06134726
Enrollment
142
Registered
2023-11-18
Start date
2021-01-15
Completion date
2023-01-15
Last updated
2023-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatoid Arthritis, Temporomandibular Joint Disorders

Keywords

Rheumatoid arthritis, Temporomandibular joints, Bruxism

Brief summary

the investigators study aimed to evaluate temporomandibular joint involvement in rheumatoid arthritis patients and healthy individuals 142 participants were recruited in two groups: 72 patients with Rheumatoid Arthritis (RA), and 70 healthy controls. All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies. TMD diagnosis was determined according to the standardized and validated diagnostic criteria for TMD (DC/TMD): myalgia, arthralgia, articular disc, displacement, degenerative joint disease, and headache attributed to TMD. Bruxism, a probable sleep and/or awake bruxism diagnosis was determined based on self-report and several clinical findings.

Interventions

DIAGNOSTIC_TESTseropositivity of rheumatoid factor

All participants were tested for seropositivity of rheumatoid factor and anticitrullinated protein antibodies

Sponsors

Syrian Private University
Lead SponsorOTHER

Study design

Observational model
CASE_CONTROL
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
35 Years to 50 Years
Healthy volunteers
Yes

Inclusion criteria

* Inclusion criteria included: * age \> 18 years old * individuals who had a minimum of 12 natural teeth. *

Exclusion criteria

* included: trauma or surgery on the jaw * facial nerve paralysis * tooth implant * scleroderma * cerebrovascular accident * schizophrenia * steroid injection within the last six months.

Design outcomes

Primary

MeasureTime frameDescription
Number of patients with prevalence of TMD2 yearspatients were interviewed, filled out the questionnaire, and examined
Number of patients with TMD-pain diagnoses2 yearspatients were interviewed, filled out the questionnaire, and examined

Countries

Syria

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026